Pandemic 2009 Influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study

F1000Research

Volumn 3, Issue , 2014, Pages

  Dignani, Maria Cecilia ^a   Costantini, Patricia ^a,b   Salgueira, Claudia ^a,c   Jordán, Rosana ^a,d   Guerrini, Graciela ^a,e   Valledor, Alejandra ^a,f   Herrera, Fabián ^a,g   Nenna, Andrea ^a,h   Mora, Claudia ^a,i   Roccia Rossi, Inés ^a,j   Stecher, Daniel ^a,b   Carbone, Edith ^a,k   Laborde, Ana ^l   Efron, Ernesto ^a,d   Altclas, Javier ^a,c   Calmaggi, Aníbal ^a,e   Cozzi, José ^a,m  

^a Argentinean Society of Infectious Diseases (SADI) Buenos Aires   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c Sanatorio de la Trinidad   (Argentina)

^d HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

^e Hospital Prof Rodolfo Rossi La Plata   (Argentina)

^f HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^g CEMIC   (Argentina)

^h Hospital Maria Curie   (Argentina)

ⁱ FLENI   (Argentina)

^j HOSPITAL SAN MARTÍN   (Argentina)

^k Hospital Aeronautico Central   (Argentina)

^l Fundacion para Combatir La Leucemia   (Argentina)

^m FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; INFLUENZA VACCINE; OSELTAMIVIR;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; CANCER PATIENT; CANDIDIASIS; CLINICAL FEATURE; FEMALE; GRAFT RECIPIENT; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPOKALEMIA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OXYGEN DESATURATION; OXYGEN SATURATION; PANDEMIC INFLUENZA; PNEUMOCOCCAL INFECTION; PNEUMOCOCCAL MENINGITIS; PNEUMONIA; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SHOCK; UPPER RESPIRATORY TRACT INFECTION;

EID: 84923206528     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.5251.1     Document Type: Article

References (40)

1. Choi SM Boudreault AA Xie H: Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients. Blood. 2011;117(19):5050-5056. 21372154 10.1182/blood-2010-11-319186 3109531
2. Chemaly RF Torres HA Aguilera EA: Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: an observational study. Clin Infect Dis. 2007;44(7):964-967. 17342649 10.1086/512374
3. Sosa Avila L Dignani MC Fernandez I: Infecciones por virus respiratorios en pacientes con enfermedades oncohematológicas y receptores de trasplante de células hematopoyéticas. IX Congreso Argentino de la Sociedad Argentina de Infectología. Mar del Plata. 2009.
4. Dawood FS Jain S Finelli L: Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360(25):2605-2615. 19423869 10.1056/NEJMoa0903810
5. Ministerio de Salud, Presidencia de la Nación de la República Argentina. Influenza Pandémica (H1N1) 2009: Informe Semana Epidemiológica N°.2010;52. Reference Source
6. Redelman-Sidi G Sepkowitz KA Huang CK: 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect. 2010;60(4):257-263. 20138188 10.1016/j.jinf.2010.01.009
7. Tramontana AR George B Hurt AC: Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg Infect Dis. 2010;16(7):1068-1075. 20587176 10.3201/eid1607.091691 3321901
8. Espinosa-Aguilar L Green JS Forrest GN: Novel H1N1 influenza in hematopoietic stem cell transplantation recipients: two centers' experiences. Biol Blood Marrow Transplant. 2011;17(4):566-573. 20708084 10.1016/j.bbmt.2010.07.018
9. Souza TM Salluh JI Bozza FA: H1N1pdm influenza infection in hospitalized cancer patients: clinical evolution and viral analysis. PLoS One. 2010;5(11):e14158. 21152402 10.1371/journal.pone.0014158 2994772
10. George B Ferguson P Kerridge I: The Clinical Impact of Infection with Swine Flu (H1N109) Strain of Influenza Virus in Hematopoietic Stem Cell Transplant Recipients. Biol Blood Marrow Transplant. 2011;17(1):147-153. 20637883 10.1016/j.bbmt.2010.07.004
11. Suyani E Aki Z Guzel O: H1N1 infection in a cohort of hematopoietic stem cell transplant recipients: prompt antiviral therapy might be life saving. Transpl Infect Dis. 2011;13(2):208-212. 21214698 10.1111/j.1399-3062.2010.00569.x
12. Ljungman P de la Camara R Perez-Bercoff L: Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients. Haematologica. 2011;96(8):1231-1235. 21546495 10.3324/haematol.2011.041913 3148919
13. Protheroe RE Kirkland KE Pearce RM: The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation study. Bone Marrow Transplant. 2012;47(1):88-94. 21358686 10.1038/bmt.2011.12
14. Rihani R Hayajneh W Sultan I: Infections with the 2009 H1N1 influenza virus among hematopoietic SCT recipients: a single center experience. Bone Marrow Transplant. 2011;46(11):1430-1436. 21243021 10.1038/bmt.2010.329
15. Minnema BJ Husain S Mazzulli T: Clinical characteristics and outcome associated with pandemic (2009) H1N1 influenza infection in patients with hematologic malignancies: a retrospective cohort study. Leuk Lymphoma. 2013;54(6):1250-1255. 23072372 10.3109/10428194.2012.740558
16. Chemaly RF Vigil KJ Saad M: A multicenter study of pandemic influenza A (H1N1) infection in patients with solid tumors in 3 countries: early therapy improves outcomes. Cancer. 2012;118(18):4627-4633. 22359314 10.1002/cncr.27447
17. Influenza Project Team. Oseltamivir resistance in human seasonal influenza viruses (A/H1N1) in EU and EFTA countries: an update. Euro Surveill. 2008;13(6):pii: 8032. 18445425
18. Martino R Ramila E Rabella N: Respiratory virus infections in adults with hematologic malignancies: a prospective study. Clin Infect Dis. 2003;36(1):1-8. 12491194 10.1086/344899
19. Martino R Porras RP Rabella N: Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transplant. 2005;11(10):781-796. 16182179 10.1016/j.bbmt.2005.07.007 3347977
20. Nichols WG Guthrie KA Corey L: Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis. 2004;39(9):1300-1306. 15494906 10.1086/425004
21. Jain S Kamimoto L Bramley AM: Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009;361(20):1935-1944. 19815859 10.1056/NEJMoa0906695
22. Casper C Englund J Boeckh M: How I treat influenza in patients with hematologic malignancies. Blood. 2010;115(7):1331-1342. 20009037 10.1182/blood-2009-11-255455 2826758
23. Girmenia C Mercanti C Federico V: Management of the 2009 A/H1N1 influenza pandemic in patients with hematologic diseases: a prospective experience at an Italian center. Acta Haematol. 2011;126(1):1-7. 21411983 10.1159/000323713
24. Chemaly RF Ghosh S Bodey GP: Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore). 2006;85(5):278-287. 16974212 10.1097/01.md.0000232560.22098.4e
25. Estenssoro E Rios FG Apezteguia C: Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med. 2010;182(1):41-48. 20203241 10.1164/201001-0037OC
26. Cao B Li XW Mao Y: Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med. 2009;361(26):2507-2517. 20007555 10.1056/NEJMoa0906612
27. Dominguez-Cherit G Lapinsky SE Macias AE: Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA. 2009;302(17):1880-1887. 19822626 10.1001/jama.2009.1536
28. Louie JK Acosta M Winter K: Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009;302(17):1896-1902. 19887665 10.1001/jama.2009.1583
29. Rello J Rodriguez A Ibanez P: Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care. 2009;13(5):R148. 19747383 10.1186/cc8044 2784367
30. Boudreault AA Xie H Leisenring W: Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virus. Biol Blood Marrow Transplant. 2011;17(7):979-986. 20870025 10.1016/j.bbmt.2010.09.014 3676866
31. Khanna N Steffen I Studt JD: Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2009;11(2):100-105. 19175540 10.1111/j.1399-3062.2008.00362.x
32. Hansen S Stamm-Balderjahn S Zuschneid I: Closure of medical departments during nosocomial outbreaks: data from a systematic analysis of the literature. J Hosp Infect. 2007;65(4):348-353. 17350731 10.1016/j.jhin.2006.12.018
33. Enstone JE Myles PR Openshaw PJ: Nosocomial pandemic (H1N1) 2009, United Kingdom, 2009-2010. Emerg Infect Dis. 2011;17(4):592-598. 21470446 10.3201/eid1704.101679 3377421
34. Engelhard D Mohty B de la Camara R: European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN. Transplant Infect Dis. 2013;15(3):219-232. 23363310 10.1111/tid.12054
35. Duvvuri VR Moghadas SM Guo H: Highly conserved cross-reactive CD4+ T-cell HA-epitopes of seasonal and the 2009 pandemic influenza viruses. Influenza Other Respir Viruses. 2010;4(5):249-258. 20716156 10.1111/j.1750-2659.2010.00161.x
36. Orellano PW Reynoso JI Carlino O: Protection of trivalent inactivated influenza vaccine against hospitalizations among pandemic influenza A (H1N1) cases in Argentina. Vaccine. 2010;28(32):5288-5291. 20541580 10.1016/j.vaccine.2010.05.051
37. Cowling BJ Ng S Ma ES: Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis. 2010;51(12):1370-1379. 21067351 10.1086/657311
38. Garcia-Garcia L Valdespino-Gomez JL Lazcano-Ponce E: Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ. 2009;339:b3928. 19808768 10.1136/bmj.b3928 2758337
39. Tu W Mao H Zheng J: Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J Virol. 2010;84(13):6527-6535. 20410263 10.1128/JVI.00519-10 2903266
40. Dignani MC Costantini P Salgueira C: Baseline characteristics, clinical presentation, treatment and outcome of 65 cancer or SCT patients. F1000Research. 2014. Data Source